Prophylactic use of low-dose interleukin-2 and the clinical outcomes of hematopoietic stem cell transplantation: A randomized study

Leukemia relapse and chronic graft-versus-host disease (cGVHD) are still major obstacles of allogeneic hematopoietic stem cell transplantation (allo-HSCT). The numbers and activity of natural killer (NK) and T-regulatory cells can be increased post-transplantation by exposure to interleukin-2 (IL-2)...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncoimmunology
Main Authors: Zhao, Xiang-Yu, Zhao, Xiao-Su, Wang, Yu-Tong, Chen, Yu-Hong, Xu, Lan-Ping, Zhang, Xiao-Hui, Han, Wei, Chen, Huan, Wang, Yu, Yan, Chen-Hua, Wang, Feng-Rong, Wang, Jing-Zhi, Liu, Kai-Yan, Chang, Ying-Jun, Huang, Xiao-Jun
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2016
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5215224/
https://ncbi.nlm.nih.gov/pubmed/28123892
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1250992
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados